NFKB1 and Miyoshi myopathy: As expected, knocking down ALKBH5 in MM cells not only led to TRAF1 suppression but also reduced the activation of downstream NF-κB and MAPK signaling molecules (Fig. 8C), which was rescued by TRAF1 restoration (Fig. 8D).